Maria Ekblad has a strong background in life science with more than 25 years of experience in drug discovery, preclinical, and clinical pharmaceutical development. She is an experienced leader with executive management positions in both line and project organizations. Some of her previous roles have included Director R&D at Follicum AB and Director of Pre-clinical development at Active Biotech AB. Maria holds a MSc in chemical engineering from Lund University.
Senior Executive Advisor
Regulatory Affairs Director
Karin Aschan has more than 30 years of experience from working with Regulatory Affairs in various positions with companies of various sizes from start-up to big pharma. She has been responsible for regulatory affairs in several international projects and the work has included a lot of interactions with authorities, development partners and vendors. The work has covered EU and US projects in all clinical trial phases through registration and maintenance work in the post-marketing phase. She has also worked within Drug Safety in clinical trials and acted as EU Pharmacovigilance QP. Karin Aschan runs her own consultancy company focusing on Regulatory Affairs. Karin holds a MSc in Pharmacy from Uppsala University.
Theresa Comiskey Olsen
Jan Nilsson holds an MA from the University of Gothenburg and an MBA from Uppsala University. He has long-standing experience from large pharmaceutical companies and biotech firms. He has also been active in several different therapy areas in the pharmaceutical industry such as pharmaceuticals development and the launch, sales and marketing of established international brands. He also has a solid management background, having served as CEO of both private and public-sector companies. Other assignments include: board member in CarryGenes Therapeutics AB, CombiGene Personal AB, Immodulate Pharma AB, Panion Animal Health AB and Urbicum Ledningskonsult AB. CEO in CombiGene AB.